OMX30 1 617 0,5%  OMXH25 3 931 1,1%  OMXC20 945 0,6%  Dow 20 996 1,1%  Nas 5 548 0,7%  EUR 9,5823 -0,5%  USD 8,7674 -1,0%  Olja 51,8 0,5%  Guld 1 264 -1,1% 

STRATEC Biomedical Aktie

53,20EUR -1,78EUR -3,24%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

STRATEC Biomedical Chart - 1 År - XETRA

Fundamentala nyckeltal för STRATEC Biomedical

2016 2017e 2018e 2019e 2020e
Utdelning 0,77 0,84 0,96 1,22 -
Direktavkastning (i %) 1,70 1,51 1,73 2,21 2,38
PE-tal 21,17 22,72 19,78 16,79 13,99
Resultat/aktie 2,14 2,43 2,79 3,29 -

Nyheter om STRATEC Biomedical AG

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om STRATEC Biomedical AG

15:07 STRATEC Biomedical Hold Deutsche Bank AG
Apr, 21 2017 STRATEC Biomedical Buy Warburg Research
Apr, 20 2017 STRATEC Biomedical Buy Warburg Research
Mar, 16 2017 STRATEC Biomedical Buy Oddo Seydler Bank AG
Mar, 15 2017 STRATEC Biomedical Hold HSBC
ytterligare analyser

STRATEC Biomedical Peer Group

Agilent Technologies 54,81
0,7%
Baxter International 53,21
-0,4%
Becton, Dickinson & 178,95
1,1%
Carl Zeiss Meditec 41,89
0,2%
Drägerwerk vz 98,49
0,7%
Fresenius Medical Care 81,54
0,3%
Gerresheimer 71,40
-0,6%
Pulsion Medical Systems 24,40
1,2%
STRATEC Biomedical 53,20
-3,2%
Smith & Nephew 12,69
0,6%
bioMerieux SA 177,80
0,1%
pagehit

Lägg till instrument

Vad tycker du?

Profil STRATEC Biomedical AGtill bolagsprofilen

STRATEC Biomedical AG designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. The company develops its products on the basis of its own patented technologies. The company operates through its segments: Instrumentation and All other segments. The Instrumentation segment designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers. The All other segments develop workflow software for networking several analyzer systems and develops and sells scientific materials and technologies such as nucleic acid purification. STRATEC Biomedical was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.

Realtidskurs STRATEC Biomedical AG

Bid
53,17
EUR
Ask
53,70
EUR
Kurstid
17:15
Börsen STU

Aktiekurs STRATEC Biomedical AG i EURPUSH CHART

Kurs 53,20 EUR -1,78 -3,24 %
Kurstid 17:36:00
Datum 25.04.2017
Öppning 54,16
Gårdagen 54,98
Dagshögsta 55,53
Dagslägsta 53,20
52 v. högsta 58,50
52 v. lägsta 41,30
52 v. perf.
Volym (Antal) 6 836
Börsvärde (SEK) 6,23 Mrd
Börsen
Kurs för 53,20 EUR från börsen XETRA motsvarar med aktuell växelkurssentspricht EUR/SEK en kurs på 509,78 SEK.

Till aktien STRATEC Biomedical

Ticker
ISIN DE000STRA555
Index Prime All Share, CDAX, Technology All Share, BX Swiss - EMEA

STRATEC Biomedical Nyckeltal

Börsvärde i SEK 6,23 Mrd
Free float % 39,77
Antal aktier mio. 11,86
Cashflow/aktie i lokal valuta 1,82
Bokvärde/aktie i lokal valuta 12,10
60 dagar vola 37,73
PBV 3,74

STRATEC Biomedical Historiska kurser

2017-04-24 54,98 20 113
2017-04-21 50,78 19 476
2017-04-20 54,07 9 859
2017-04-19 54,00 10 093
2017-04-18 54,37 9 313

Aktier i samma industri med bättre 1 års perf.

m-u-t AG Meßgeräte für Medizin- und Umwelttechnik 77,8 %
CyBio AG 54,6 %
Sartorius AG Vz. 45,9 %
Sartorius AG St. 20,6 %
Pandatel AG 17,8 %

Riktkurser för STRATEC Biomedical

Sell
Hold
Buy
50
55
60
65
70